Objectives. To evaluate trends in prostate sampling and the efficacy o
f different sampling methods to detect prostate cancer in subsequent b
iopsies after an initial ''atypical'' biopsy. Methods. We searched Dia
non Systems from March 1994 to June 1996 for cases with an initial aty
pical diagnosis on biopsy and that had repeat biopsies. The files of D
ianon and Johns Hopkins Hospital (JHH) were also analyzed for cases wi
th an initial atypical diagnosis on sextant biopsy and for repeat sext
ant biopsies showing cancer. Results. Of the 124 Dianon cases in which
we knew the site (sextant, left, right) of the initial and subsequent
biopsies, 56 cases (45.2%) were cancer on repeat biopsy; in cases wit
h repeat sextant biopsies, cancer was detected 59.3% of the time. Ther
e were 54 cases in which the initial biopsy was atypical and the repea
t biopsy was cancer, where both sets of biopsies were sextants (44 Dia
non, 10 JHH). Of the 46 cases with only one initial atypical site, the
cancer was in the same sextant site as the previously atypical biopsy
in 47.8% of cases; cancer was detected in 84.8% of the cases in eithe
r the same sextant, adjacent ipsilateral, or adjacent contralateral si
tes. Conclusions. Great variation exists in how urologists sample pros
tates both initially and after an atypical diagnosis. Of the 149 Diano
n cases, only 32 were sextant to sextant biopsies, and another 32 were
consistently left and right to left and right. Our study shows that i
n subsequent biopsies after an atypical biopsy, the chance of detectin
g cancer greatly increases with biopsy not only of the atypical site,
but adjacent contralateral and adjacent ipsilateral areas as well. We
advocate the precise labeling of the initial biopsies so that rebiopsy
of atypical cases can be directed in a more concentrated fashion into
the region of the initial atypical biopsy. Other sites should be biop
sied as well, which urologists did not always do, because cancer may a
lso be found away from the initial atypical site. (C) 1998, Elsevier S
cience Inc. All rights reserved.